Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The 2022 World Health Organization Classification of Tumors of the Urinary System and Male Genital Organs—Part B: Prostate and Urinary Tract Tumors
George J. Netto, Mahul B. Amin, Daniel M. Berney, et al.
European Urology (2022) Vol. 82, Iss. 5, pp. 469-482
Closed Access | Times Cited: 176

Showing 26-50 of 176 citing articles:

Solitary testicular metastasis post-prostatectomy for prostatic ductal adenocarcinoma: case report and literature review
Bo Chang, Manqing Zhang, Yifan Hou, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access
Adhesion-regulating molecule 1 (ADRM1) can be a potential biomarker and target for bladder cancer
Qing-xin Yu, Jiaochen Wang, Jun-fei Liu, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 10
The Association between Urinary Diversion Type and Other-Cause Mortality in Radical Cystectomy Patients
Simone Morra, Lukas Scheipner, Andrea Baudo, et al.
Cancers (2024) Vol. 16, Iss. 2, pp. 429-429
Open Access | Times Cited: 3
A natural nano-platform: Advances in drug delivery system with recombinant high-density lipoprotein
Zhilong Xie, Guohui Zhang, Ya Meng, et al.
Chinese Chemical Letters (2024) Vol. 35, Iss. 11, pp. 109584-109584
Closed Access | Times Cited: 3
Multiomics profiling of urothelial carcinoma in situ reveals CIS-specific gene signature and immune characteristics
Meenakshi Anurag, Trine Strandgaard, Sung Han Kim, et al.
iScience (2024) Vol. 27, Iss. 3, pp. 109179-109179
Open Access | Times Cited: 3
Ductal, intraductal, and cribriform carcinoma of the prostate: Molecular characteristics and clinical management
Yibo Shi, Hanzhang Wang, Borivoj Golijanin, et al.
Urologic Oncology Seminars and Original Investigations (2024) Vol. 42, Iss. 5, pp. 144-154
Closed Access | Times Cited: 3
IL-38 promotes the development of prostate cancer
Huiyan Wu, Jing Yang, Liuhong Yuan, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 3
Diagnostic Test Accuracy of Urinary DNA Methylation-based Biomarkers for the Detection of Primary and Recurrent Bladder Cancer: A Systematic Review and Meta-analysis
Mariana Silva-Ferreira, João Andrade de Carvalho, Sofia Salta, et al.
European Urology Focus (2024)
Closed Access | Times Cited: 3
Life expectancy in rare histological prostate cancer subtypes
Carolin Siech, Mario de Angelis, Letizia Maria Ippolita Jannello, et al.
International Journal of Cancer (2024)
Open Access | Times Cited: 3
Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype
Ana Blanca, Antonio López-Beltrán, Kevin Lopez-Porcheron, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2149-2149
Open Access | Times Cited: 9
P2X1 and P2X7 Receptor Overexpression Is a Negative Predictor of Survival in Muscle-Invasive Bladder Cancer
Stephan Ledderose, Severin Rodler, Lennert Eismann, et al.
Cancers (2023) Vol. 15, Iss. 8, pp. 2321-2321
Open Access | Times Cited: 9
Novel immunotherapeutic options for BCG‐unresponsive high‐risk non‐muscle‐invasive bladder cancer
Zein Alabdin Hannouneh, A Hijazi, Alaa Aldeen Alsaleem, et al.
Cancer Medicine (2023) Vol. 12, Iss. 24, pp. 21944-21968
Open Access | Times Cited: 9
Machine learning models combining computed tomography semantic features and selected clinical variables for accurate prediction of the pathological grade of bladder cancer
Zhikang Deng, Wentao Dong, Situ Xiong, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 8
Second-Line Systemic Therapy for Highly Aggressive Neuroendocrine Prostate Cancer
Naohiro Fujimoto, Yuto Tsubonuma, Yujiro Nagata, et al.
Anticancer Research (2023) Vol. 43, Iss. 9, pp. 3841-3847
Open Access | Times Cited: 8
Genomic and Evolutionary Characterization of Concurrent Intraductal Carcinoma and Adenocarcinoma of the Prostate
Jinge Zhao, Nanwei Xu, Sha Zhu, et al.
Cancer Research (2023) Vol. 84, Iss. 1, pp. 154-167
Closed Access | Times Cited: 8
MiR‐15b‐5p inhibits castration‐resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3
Shunichi Asai, Yusuke Goto, Kengo Tanigawa, et al.
FEBS Letters (2023) Vol. 597, Iss. 8, pp. 1164-1175
Closed Access | Times Cited: 7
Uncovering the Secrets of Prostate Cancer’s Radiotherapy Resistance: Advances in Mechanism Research
Feng Lyu, Shiyu Shang, Xianshu Gao, et al.
Biomedicines (2023) Vol. 11, Iss. 6, pp. 1628-1628
Open Access | Times Cited: 7
The Oncological and Functional Prognostic Value of Unconventional Histology of Prostate Cancer in Localized Disease Treated with Robotic Radical Prostatectomy: An International Multicenter 5-Year Cohort Study
David Leung, Daniele Castellani, Rossella Nicoletti, et al.
European Urology Oncology (2024) Vol. 7, Iss. 3, pp. 581-588
Closed Access | Times Cited: 2
SMMF: a self-attention-based multi-parametric MRI feature fusion framework for the diagnosis of bladder cancer grading
Tingting Tao, Huiling Chen, Yunyun Shang, et al.
Frontiers in Oncology (2024) Vol. 14
Open Access | Times Cited: 2
Prognostic significance of circulating tumor DNA in urothelial carcinoma: a systematic review and meta-analysis
Haoyang Liu, Junru Chen, Yuchen Huang, et al.
International Journal of Surgery (2024)
Open Access | Times Cited: 2
Expert Perspectives on Controversies in Metastatic Castration-Resistant Prostate Cancer Management: Narrative Review and Report of the First US Prostate Cancer Conference Part 2
Alan H. Bryce, E. David Crawford, Neeraj Agarwal, et al.
JU Open Plus (2024) Vol. 2, Iss. 4
Open Access | Times Cited: 2
Treatment-induced neuroendocrine prostate cancer and de novo neuroendocrine prostate cancer: Identification, prognosis and survival, genetic and epigenetic factors
Mohamed Wishahi
World Journal of Clinical Cases (2024) Vol. 12, Iss. 13, pp. 2143-2146
Open Access | Times Cited: 2
Survival benefit of nephroureterectomy in systemic therapy exposed metastatic upper tract urinary urothelial carcinoma patients
Simone Morra, Reha‐Baris Incesu, Lukas Scheipner, et al.
World Journal of Urology (2024) Vol. 42, Iss. 1
Closed Access | Times Cited: 2
Prostate Adenocarcinoma with Signet-Ring Cells and Features of Mucin: A Clinical Case and Literature Review
Migle Sakalauskaite, Aušra Garnelytė, Ignas Civilka, et al.
Medicina (2024) Vol. 60, Iss. 6, pp. 877-877
Open Access | Times Cited: 2
Amide Proton Transfer‐Weighted Imaging in Assessing the Aggressive and Proliferative Potential of Bladder Cancer
Lingmin Kong, Hui Li, Qian Cai, et al.
Journal of Magnetic Resonance Imaging (2024)
Closed Access | Times Cited: 2

Scroll to top